MedPath

Biosimilar Collaborations Ireland Ltd.

🇮🇪Ireland
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

41

EMA:13
CIMA_AEMPS:12
CANADA:8

Drug Approvals

Evfraxy

Authorization Status
Authorised
Approval Date
Jun 30, 2025
EMA

Vevzuo

Authorization Status
Authorised
Approval Date
Jun 25, 2025
EMA

Vevzuo

Authorization Status
Authorised
Approval Date
Jun 25, 2025
EMA

Yesintek

Authorization Status
Authorised
Approval Date
Feb 14, 2025
EMA

Yesintek

Authorization Status
Authorised
Approval Date
Feb 14, 2025
EMA

Yesafili

Authorization Status
Authorised
Approval Date
Sep 15, 2023
EMA

Yesafili

Authorization Status
Authorised
Approval Date
Sep 15, 2023
EMA

Abevmy

Authorization Status
Authorised
Approval Date
Apr 21, 2021
EMA

Kirsty (previously Kixelle)

Authorization Status
Authorised
Approval Date
Feb 5, 2021
EMA

Nepexto

Authorization Status
Authorised
Approval Date
May 20, 2020
EMA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.